Explore the full directors' dealings record of Bicara Therapeutics Inc., a listed issuer based in United States. Shares are quoted on US US, under the oversight of SEC (Form 4). Market capitalisation: €1.4bn. The latest transaction was disclosed on 26 May 2026 (Levée d'options). Among the most active insiders: Hyep Ivan. Every trade is accessible without an account.
13
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
€271,311
3 ops.
Sell Volume
39Σ signal
Buys ·€271,311 Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.